Sambial, Jeff P.
HRN: 22-93-12 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/18/2023
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
04/18/2023
04/25/2023
PO
1.8 Ml
TID
PCAP- C, Impetigo
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes